.webp?width=200&height=52&name=SDC-01%20(1).webp "SDC-01 (1)")
THERAPY AREAS
Clinical Development Expertise Across High-Impact Therapeutic Areas
Successful clinical development requires more than operational execution—it requires therapeutic insight.
Therapy Types and Therapeutic Areas We Support
Our experience extends across pharmaceutical and biotech programs, medical devices and diagnostics, biologics, regenerative medicine, rare and genetic diseases, pediatric populations, and vaccine development—providing sponsors with the expertise to navigate complex clinical and regulatory pathways with confidence.
While our recent experience has been heavily concentrated in ophthalmology, oncology, and neurology/CNS, our multidisciplinary teams bring deep expertise across a broad range of therapeutic areas, enabling us to support complex development programs from early-phase studies through regulatory submission and commercialization.
- Cardiovascular Disease
- Dermatology
- Dental/Oral Health
- Endocrinology
- Gastroenterology
- Hematology
- Infectious Disease
- Musculoskeletal
- Nephrology
- Respiratory
- Rheumatology
- and more
Ophthalmology Expertise Across the Development Lifecycle
With experience supporting 600+ ophthalmology studies, SDC helps sponsors design, manage, analyze, and submit ophthalmic clinical programs from Phase 1 through regulatory approval. Our team has also helped shape industry standards, including support for ophthalmology CDISC development.
Key Experience
- 600+ ophthalmology studies supported
- 20+ product approvals
- Device, diagnostic, and drug development expertise
- Adaptive trial design and pooled analysis capabilities
- Regulatory submission support
Ophthalmology indications include:
- AMD
- DME
- RVO
Glaucoma & Ocular Hypertension
Corneal & Ocular Surface Disease
- Dry Eye
- Keratitis
- Corneal Disorders
- Anterior/Posterior Chamber Inflammation
- Post-Operative Inflammation
Oncology Expertise Across the Development Lifecycle
Supporting the Next Generation of Cancer Therapies
SDC provides oncology expertise across a broad range of tumor types and study designs, supporting programs from early-phase development through global Phase 3 trials and regulatory interactions.
Key Experience
- 100+ oncology studies supported
- Early-phase through global Phase 3 experience
- Adaptive and Bayesian trial designs
- Global regulatory expertise with 10+ cancer submissions supported
Cancer indications include:
Solid Tumors
- Brain
- Breast
- Head & Neck
- Lung
- Gastrointestinal
- Genitourinary
- Prostate
- Leukemias
- Lymphomas
- Multiple Myeloma (MM)
Neurology & CNS Expertise Across the Development Lifecycle
SDC supports pharmaceutical, diagnostic, and medical device studies across a variety of neurological conditions. Our experienced teams provide full-service support from early-phase development through pivotal trials and regulatory submission.
Key Experience
- 50+ CNS/Neurodegenerative disease studies supported
- Pharmaceutical, device, and diagnostic expertise
- Early-phase through pivotal studies
- PK, MAD, and complex study designs
- Full-service clinical development support
Neurological Diseases and CNS indications:
- Alzheimer's Disease
- Parkinson's Disease
- ALS
Neurodevelopmental Disorders
Neuromuscular Disorders
Epilepsy & Seizure Disorders
Rare Neurological Diseases
CNS Diagnostics & Devices, and more...
Bring Proven Therapeutic Expertise to Your Next Study
Whether you're advancing a first-in-human program or preparing for regulatory submission, SDC provides the therapeutic insight, technology-enabled solutions, and operational expertise needed to accelerate development and empower better clinical decisions.